Patient recruitment is still considered by sponsors, CROs and research sites as the biggest challenge to the successful development and marketisation of new therapies and medications, as was highlighted in our latest whitepaper.
Although in recent years, an increasing number of third-party providers have started offering patient recruitment services, most of these lack the expertise that ensures the quick start of recruitment and on-schedule completion of the study.
Despite the increasing focus on patient recruitment, study delays are in fact increasing. To read more, please download this free white paper.
Thank you.Please check your email to download the white paper.